Back to Journals » Cancer Management and Research » Volume 14

Real-World Outcomes and Prognostic Factors Among Patients with Advanced Non-Small Cell Lung Cancer and High PD-L1 Expression Treated with Immune Checkpoint Inhibitors as First-Line Therapy

Total article views   HTML views PDF downloads Totals
4,222 Dovepress* 3,863+ 92 3,955
PubMed Central* 359 147 506
Totals 4,222 239 4,461
*Since 16 November 2022

View citations on PubMed Central and Google Scholar